Levetiracetam in the Management of Bipolar Depression



Status:Completed
Conditions:Depression, Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - 65
Updated:4/21/2016
Start Date:October 2005
End Date:August 2008

Use our guide to learn which trials are right for you!

A 6-week outpatient, double-blind, placebo-controlled, add-on trial to investigate the
effects of levetiracetam on depressive symptoms in bipolar depressed patients.


Inclusion Criteria:

- DSM-IV diagnosis of bipolar disorder

- Presence of a current major depressive episode on the SCID

- Score of 17 or great on the HDRS

- Capable of giving voluntary written consent

Exclusion Criteria:

- Significant current substance dependence/abuse within 3 months preceding the trial

- Active suicidal ideation

- Pregnant/lactating mothers

- Significant medical history
We found this trial at
1
site
333 Cedar St
New Haven, Connecticut 06504
(203) 432-4771
Yale University School of Medicine Founded in 1810, the Yale School of Medicine is a...
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials